Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-046534

Rubius Therapeutics, Inc. · RUBY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Noubar Afeyan
Director · 10% Owner
Period of report
Jul 20, 2018
Accepted (ET)
Jul 23, 2018 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001709401

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jul 20, 2018C15,323,593—A15,323,593ISee Footnote
Common StockF2,F4Jul 20, 2018C3,830,402—A3,830,402ISee Footnote
Common StockF2,F5Jul 20, 2018C5,000,000—A5,000,000ISee Footnote
Common StockF2,F6Jul 20, 2018C5,000,000—A5,000,000ISee Footnote
Common StockF2,F5Jul 20, 2018C593,948—A5,593,948ISee Footnote
Common StockF2,F6Jul 20, 2018C593,948—A5,593,948ISee Footnote
Common StockF2,F7Jul 20, 2018C1,781,843—A1,781,843ISee Footnote
Common StockF2,F5Jul 20, 2018C195,466—A5,789,414ISee Footnote
Common StockF2,F6Jul 20, 2018C195,466—A5,789,414ISee Footnote
Common StockF2,F7Jul 20, 2018C781,860—A2,563,703ISee Footnote
Common StockF1holding———5,000,000ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF2,F3—Jul 20, 2018C15,323,593D——Common Stock15,323,5930I
Series A Preferred StockF2,F4—Jul 20, 2018C3,830,402D——Common Stock3,830,4020I
Series A Preferred StockF2,F5—Jul 20, 2018C5,000,000D——Common Stock5,000,0000I
Series A Preferred StockF2,F6—Jul 20, 2018C5,000,000D——Common Stock5,000,0000I
Series B Preferred StockF2,F5—Jul 20, 2018C593,948D——Common Stock593,9480I
Series B Preferred StockF2,F6—Jul 20, 2018C593,948D——Common Stock593,9480I
Series B Preferred StockF2,F7—Jul 20, 2018C1,781,843D——Common Stock1,781,8430I
Series C Preferred StockF2,F5—Jul 20, 2018C195,466D——Common Stock195,4660I
Series C Preferred StockF2,F6—Jul 20, 2018C195,466D——Common Stock195,4660I
Series C Preferred StockF2,F7—Jul 20, 2018C781,860D——Common Stock781,8600I

Explanation of responses